Billionaire Ken Fisher’s Latest Stock Picks Include Pfizer and Visa

Page 1 of 2

Fisher Asset Management, which is managed by billionaire investor/author/Forbes columnist Ken Fisher, has released its 13F filing for December 2012, disclosing many of its long equity positions. Investors can use these filings as a way to see which stocks a manager likes or to get a more general impression of how the manager is looking at the markets. We have gone through the filing and picked out five of Fisher’s largest holdings by market value as of the beginning of the year Read on for our quick take on these stocks and compare them to previous filings.

FISHER ASSET MANAGEMENT

The fund’s top pick was Pfizer Inc. (NYSE:PFE) with the fund selling a very small amount of what had been its largest holding three months earlier as well.  Pfizer trades at 21 times trailing earnings but Wall Street analysts expect net income to be considerably better this year: the current-year P/E is only 12. This is the case despite double-digit percentage decreases in revenue and earnings in Q3 2011 versus a year earlier. In its most recent 13F filing, Tiger Cub Rob Citrone’s Discovery Capital Management had Pfizer as one of the top holdings in its portfolio. We think that we would wait to see if the company’s financials are actually going to be on target.

Fisher owned 4.9 million shares of Visa Inc (NYSE:V), up slightly from the beginning of October. With Visa gaining in price since that time, it moved into the fund’s top five picks. Visa is another stock where investors have to look ahead: the stock is valued at 19 times consensus earnings for the fiscal year ending in September 2014. Revenue and earnings have been up, and we like the credit card business’s exposure to payment volumes (as opposed to credit risk which is held by banks), but we think we’d avoid Visa at that multiple. Billionaire Stephen Mandel’s Lone Pine Capital owned 2.9 million shares at the end of the third quarter (check out Mandel’s stock picks).

Johnson & Johnson (NYSE:JNJ) was another of Fisher’s favorite stocks with the fund reporting a position of over 10 million shares- down slightly from the fund’s 13F for the third quarter of the year. In our recent analysis of Johnson & Johnson (read our analysis of the company), we thought that it too was too dependent on seeing future growth for us to recommend buying: its trailing P/E is 24 and the business has been struggling recently. There was an abnormal increase in research and development, but even accounting for that the growth rate in pretax income was very light.

Fisher also liked two tech stocks:

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

The 10 Highest Rated Movies of 2014

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!